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DObjective: In natural history studies, increased left ventricular mass and wall thickness are strongly associated
with increased late mortality in patients with hypertrophic cardiomyopathy. Our objective was to determine the
impact of left ventricular mass and wall thickness on survival after myectomy for hypertrophic obstructive
cardiomyopathy.
Methods: We reviewed the case histories of 796 patients who underwent transaortic septal myectomy for hy-
pertrophic obstructive cardiomyopathy from January 1993 to December 2006. We then selected for study pa-
tients who had transthoracic echocardiography within 30 days after myectomy, which included complete
measurements of interventricular wall thickness, posterior wall thickness, and left ventricular end diastolic
dimension. Late survival was determined for all patients using medical records and surveys.
Results: Our study group included 416 patients with a mean age of 50  15 years, and 58% were male. Eight
percent of patients had coronary artery disease, 17% had a history of arrhythmia, and 17% had a previous or
concomitant insertion of an internal cardioverter defibrillator. All patients had successful myectomy, and
17% required an additional mitral valve procedure, most often mitral valve repair. On predismissal echocardio-
graphy, the average interventricular wall thickness was 16 5 mm, the posterior wall thickness was 13 3 mm,
and the left ventricular end diastolic dimension was 45 6 mm. The indexed left ventricular mass was 135 46
g/m2. Late survival at 1, 5, and 10 years was 99%, 97%, and 85%, which was similar to that of an age- and
gender-matched population (P ¼ .453). On multivariate analysis, preoperative and postoperative wall thickness
and left ventricular mass were not associated with death; only a history of coronary artery disease (hazard ratio
4.9) was predictive of late mortality.
Conclusions: Left ventricular mass and wall thickness were not predictors of late survival after myectomy for
hypertrophic obstructive cardiomyopathy, and this is in contrast to natural history studies of patients who were
not treated surgically. Late survival was similar to that of an age- and gender-matched population. (J Thorac Car-
diovasc Surg 2011;141:439-43)Patients with hypertrophic cardiomyopathy (HCM) may
have resting or provoked gradients owing to outflow tract
obstruction caused by basal septal hypertrophy and systolic
anterior motion of the mitral valve apparatus. In these
patients, who are often symptomatic, transaortic septal
myectomy can successfully relieve gradients. In multiple
studies,1-3 septal myectomy for hypertrophic obstructive
cardiomyopathy (HOCM) has been shown to have a low
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The Journal of Thoracic and Casurvival of patients after myectomy is similar to that of an
age- and gender-matched population.
The mechanism whereby septal myectomy improves sur-
vival of patients with HOCM is poorly understood. In pa-
tients with obstructive or nonobstructive HCM who are
not treated surgically, a correlation between left ventricular
(LV) wall thickness and risk of sudden death, progression to
heart failure, and overall death has been identified.4 Our ob-
jective was to determine the impact of LV wall thickness
and LV mass on survival after septal myectomy for HOCM.
METHODS
After obtaining appropriate institutional review board approval waiving
the need to obtain specific patient consent, we reviewed the case histories of
796 patients who underwent myectomy for HOCM from January 1993 to
December 2006. Patients were selected for further study if complete early
postoperative (<30 days) transthoracic echocardiography was available.
Datawere collected fromboth prospective clinical databases and a prospec-
tive echocardiographic database. Late survival was determined for all
patients from medical records, Accurint (www.accurint.com), and surveys.
Echocardiography was considered complete if it included comprehen-
sive measurements of interventricular septal wall thickness (IWT),rdiovascular Surgery c Volume 141, Number 2 439
Abbreviations and Acronyms
HCM ¼ hypertrophic cardiomyopathy
HOCM ¼ hypertrophic obstructive
cardiomyopathy
ICD ¼ internal cardioverter defibrillator
IWT ¼ interventricular septal wall thickness
LV ¼ left ventricle (ventricular)
MWT ¼ maximal wall thickness
PWT ¼ posterior wall thickness
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Dposterior wall thickness (PWT), and LVend-diastolic dimensions.Maximal
wall thickness (MWT) was considered to be the thickest wall of the LV
(posterior or septal). Echocardiographic measurements were performed ac-
cording to the standards described by the American Association for Echo-
cardiography.5 We analyzed both the premyectomy and postmyectomy
value for the IWT to account for any possible error resulting from a mea-
surement in the myectomy trough. All measurements were also indexed to
body surface area.
Statistical analyses were performed using SAS software (version 9.1;
SAS Institute, Inc, Cary, NC). Data are presented as means and standard
deviations or numbers and percentages, as appropriate. Univariate and step-
wise multivariate models were created using logistic regression for binary
outcomes and Cox proportional hazards for time-related data. Kaplan–
Meier curves were compared using a log–rank test.RESULTS
Our study group included 416 patients with a mean age of
50  15 years, and 58% were male. Eight percent of
patients had coronary artery disease, 17% had a history of
arrhythmia, and 17% had a previous or concomitant inser-
tion of an internal cardioverter defibrillator (ICD) (Table 1).
Before the operation, the mean echocardiographic
measurement of IWT was 19.4  5.6 mm, PWT was
14.0 3.3 mm, and MWTwas 19.5 5.6 mm. The average
LV end-diastolic dimension was 44.9  6.3 mm and LV
mass index was 162.5 55.8 g/m2. The mean ejection frac-
tion was 72%  6%.
All patients had successful myectomy, and 17% required
an additional mitral valve procedure including chordal or
papillary muscle division or resection (n¼ 34), mitral valve
replacement (n ¼ 9), leaflet only repair (n ¼ 15), leaflet re-
pair and annuloplasty (n¼ 7), or annuloplasty alone (n¼ 6).
Forty-one patients required aortic valve procedures, with
aortic valve replacement (n ¼ 21) the most common for
concomitant aortic stenosis. Coronary artery bypass was
performed in 28 patients and a maze procedure in 11
patients.
On predismissal echocardiography, the average IWTwas
15.9  4.9 mm, the PWT was 13.1  2.9 mm, and the LV
end-diastolic dimension was 44.5  6.4 mm. The average
indexed LV mass was 134.7  45.9 g/m2 and the MWT
was 16.3  14.7 mm after subaortic septal myectomy.
The ejection fraction was 66%  7% at dismissal.440 The Journal of Thoracic and Cardiovascular SurgThe mean follow-up time was 3.6  3.2 years. Late sur-
vival at 1, 5, and 10 years was 99%, 97%, and 85%, which
was similar to an age- and gender-matched Minnesotan
population (P ¼ .453) (Figure 1). Univariate analysis is
shown in Table 2. Significant univariate associations with
mortality included older age, presence of coronary artery
disease, and lower preoperative ejection fraction. Survival
was similar for patients with and without ICDs. Wall thick-
ness was not a univariate predictor of survival when consid-
ered as a continuous or integer variable (Figure 2). On
multivariate analysis, wall thickness (preoperative and pre-
dismissal) and LV mass were not associated with death;
only a history of coronary artery disease (hazard ratio 4.9;
P ¼ .006) was predictive of late mortality (Figure 3).
DISCUSSION
In this study of patients who underwent transaortic sub-
aoertic septal myectomy for HOCM,measures of LV hyper-
trophy (IWT, PWT, MWT, LV mass, and indexed values)
were not associated with late death. Our findings differ
from the natural history of patients with HCM who were
not treated surgically. In a study of 480 patients who were
followed up over a mean interval of 6.5 years, Spirito and
associates4 found a strong correlation between degree of
ventricular hypertrophy (defined as MWT) and sudden car-
diac death. Indeed, in their investigation, the cumulative
risk of sudden death 20 years after diagnosis was negligible
for patients with a wall thickness of 19 mm or less but al-
most 40% for patients with wall thicknesses of 30 mm or
more. Only 25% of the overall group had outflow tract ob-
struction, and only 5.4% had surgery for septal myectomy.4
The present study differs in several important ways. Our
study patients appear to have less severe concentric ventric-
ular hypertrophy than do those in the natural history study
who had an average MWT of 21  5 mm including 43 pa-
tients (9%) with an MWTof 30 mm or more.4 In our study,
only 18 (4%) patients had a preoperativeMWTof 30 mm or
more. It may be that patients selected for surgery who have
marked basal hypertrophy have less severe thickening of the
remainder of the ventricle.
As well, our study patients were more severely symptom-
atic, inasmuch as 81%were in NewYork Heart Association
class III or IV compared with only 7% in the investigation
by Spirito and associates.4 In a study from Italy of HOCM
patients with severe symptoms, deteriorating functional
class became a predictor of cardiovascular death, indepen-
dent of outflow tract gradient.6 Spirito’s group4 reported
that extreme hypertrophy was associated with younger
age but not associated with advanced symptoms. We did
not include children in our study, whereas their study
included some patients less than 18 years of age.
Finally, our analysis includes both unindexed and
indexed values for LV hypertrophy. Although we acknowl-
edge Spirito and colleagues’4 arguments for using the moreery c February 2011
TABLE 1. Patient demographics
Variable Mean ± SD
Age (y) 50  15
Body surface area (m2) 2.0  0.2
Ejection fraction (%) 72  6
N (%)
Male 242 (58)
Coronary artery disease (MI or CABG) 34 (8)
Angina 153 (37)
New York Heart Association class III or IV 337 (81)
History of congestive heart failure 40 (10)
History of arrhythmia 72 (17)
Preoperative or concomitant ICD 69 (17)
MI, Myocardial infarction; CABG, coronary artery bypass grafting; ICD, internal
cardioverter defibrillator.
TABLE 2. Univariate predictors of mortality
Preoperative clinical variables P value
Coronary artery disease .006*
Older age (1 y) .020*
New York Heart Association class III or IV .136
Male gender .334
Congestive heart failure .554
Preoperative/concomitant internal cardiac defibrillator .845
Angina .872
Preoperative arrhythmia .905
Echocardiographic variablesy P value
Preoperative
Decreasing ejection fraction (1%) .044*
Interventricular wall thickness .843
Indexed interventricular wall thickness .392
Postoperative
Interventricular wall thickness .065
Indexed interventricular wall thickness .885
Posterior wall thickness .279
Indexed posterior wall thickness .070
Left ventricular end-diastolic dimension .057
Indexed left ventricular end-diastolic dimension .557
Left ventricular mass .402
Indexed left ventricular mass .681
Maximal wall thickness .733
Indexed maximal wall thickness .776
*Significant univariate associations with mortality. yAll echocardiographic variables
were analyzed in a continuous fashion.
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data to provide a more complete analysis. We did not find
indexed values to be superior to the unindexed measures
in our study.
In a study by Sorajja and colleagues,7 patients who had
massive myocardial hypertrophy (myocardial thickness
30 mm) had a poorer survival than did an age- and
gender-matched population. The most common cause of
death was sudden cardiac death in young (<30 years) pa-
tients and heart failure in older (60 years) patients. These
authors did not identify any excess mortality in middle-aged
patients. Our study differs, in that this cohort includes pa-
tients with HOCMwho had surgical relief of the LVoutflow
tract obstruction.
LVoutflow tract obstruction appears to be a risk factor for
poor outcome in patients with HCM.8,9 The presence of
a resting LV outflow tract gradient of 30 mm Hg or more
is reported to be an independent predictor (odds ratio 4.4)
of progression to heart failure and death from heart failure
or stroke in patients with HCM.8 However, in the studyFIGURE 1. Overall survival after transaortic interventricular septal
myectomy for hypertrophic obstructive cardiomyopathy compared with
an age- and gender-matched Minnesotan, white population.
The Journal of Thoracic and Caby Ommen and colleagues1 from our clinic, patients with
obstruction who subsequently had interventricular septal
myectomy had improved survival (hazard ratio 0.43) com-
pared with patients not treated surgically, and this associa-
tion was independent of other clinical or hemodynamic
characteristics. The difference in survival of HOCM pa-
tients with or without septal myectomymay be related to re-
lief of the hemodynamic burden and/or improvement in
diastolic function. Improvement of mitral inflow Doppler
velocity curves and decreased mitral E velocity suggest en-
hancement of diastolic filling after surgical myectomy.10
The improvement in diastolic function may be due to a de-
crease in subendocardial ischemia resulting from lower
intracavitary pressure after myectomy.
Subaortic septal myectomy also results in LV mass
regression after successful relief of the LVoutflow tract ob-
struction. In prior studies from our clinic, LV mass regres-
sion has been shown to occur early postoperatively and
persist up to 2 years after operation.10,11 At less than 2
years after myectomy, a statistically significant reduction
in the IWTand PWTwas demonstrated.11 We did not exam-
ine late echocardiography in our study patients and thus
cannot assess the potential role of LV mass regression
over time.
Improved survival after septal myectomy may be related
to decreased risk of sudden cardiac death. McLeod andrdiovascular Surgery c Volume 141, Number 2 441
FIGURE 2. Survival stratified by preoperative maximal wall thickness. A
maximal wall thickness of 30 mm or more was considered massive hyper-
trophy. FIGURE 3. Survival stratified by presence or absence of coronary artery
disease.
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Dcolleagues12 reviewed 125 patients with HCM who had
ICDs and stratified patients into groups who did or did
not undergo myectomy. The average annualized event rate
(sudden death or appropriate ICD discharge) was 4.3%
per year in the nonmyectomy group and 0.24% per year af-
ter myectomy (P ¼ .004). The mechanism responsible for
the lower risk of ventricular arrhythmias after myectomy
is unknown, but the decrease in LV pressure may be a con-
tributor. The late (>5 years) frequency of sudden death after
myectomy, however, remains uncertain, and ongoing
assessment for the risk of sudden death is important.
It is notable that survival after subaortic septal myectomy
in this series was similar for patients with and without ICDs,
but these data should be interpreted with caution. Recent
guidelines13 advise placement of a prophylactic ICD in pa-
tients with HCM who have a major risk factor for sudden
death (prior cardiac arrest, spontaneous sustained ventricu-
lar tachycardia, family history of sudden cardiac death, syn-
cope, an abnormal blood pressure response to exercise, and
massive LV hypertrophy  30 mm). However, our study
contained only 18 premyectomy patients and 9 postmyec-
tomy with an MWT of 30 mm or more. Thus, our results
may not be applicable in patients with severe ventricular hy-
pertrophy. Almost 17% of our patients had an ICD either
preoperatively or at the time of the operation, but we did
not find that an ICD was protective in our patients.
In this cohort of patients, the only associations with late
mortality were older age, coronary artery disease, and lower
preoperative ejection fraction. On multivariate analysis,
only coronary artery disease was predictive of late mortal-
ity. These risk factors would be similar to the common pre-
dictors of mortality in a generalized population. Coronary
artery disease has previously been shown to impend
a poor prognosis in patients with HCM, both surgically
treated and not surgically treated.14
We used the clinically reported measurements on
echocardiography for all patients. We did not remeasure442 The Journal of Thoracic and Cardiovascular Surgechocardiograms because this is the clinical information
that was provided to make decisions regarding therapy. It
is possible that the preoperative IWT and postoperative
IWT measurements were taken in either the bulge of the in-
terventricular septum or in myectomy trough. In an effort to
account for this, both preoperative and postoperative mea-
surements of IWT were included in our analysis. We also
used both nonindexed and indexed values and calculated
the MWT, which is a measurement reported in previous
studies.1,4CONCLUSIONS
The preoperative and postoperative LV mass and wall
thickness, as well as the echo changes observed within
1 month of myectomy, were not predictors of late survival
after myectomy for HOCM, and this is in contrast to natural
history studies of patients who are not treated surgically.
Late survival was similar to that of an age- and gender-
matched population up to 10 years after myectomy.
Longer-term follow-up is needed to determine both the
mechanism of the improved survival and the duration of
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